高密度脂蛋白功能障碍和动脉样性心血管疾病:从数量到质量
Amogh Jyothi Arun1, Shigeru Kaneki1, Madiha Baig1
1From the Department of Medicine, New York Medical College, Valhalla, NY.
Cardiology in review
|November 14, 2025
概括
高密度脂蛋白胆固醇 (HDL-C) 的数量并不能保证心血管保护. 焦点正在转移到HDL质量和功能,以更好地评估风险和向治疗.
科学领域:
- 心血管医学 心血管医学
- 生物化学 生物化学
- 蛋白质组学是指蛋白质组学.
背景情况:
- 高密度脂蛋白胆固醇 (HDL-C) 与动脉样硬化心血管疾病 (ASCVD) 风险相反相关.
- 提高HDL-C水平的药理学策略并没有减少心血管事件.
- 现在的研究强调HDL的质量和功能,而不是数量.
研究的目的:
- 探索重点从HDL-C数量转向HDL质量和功能的转变.
- 了解HDL功能障碍的机制.
- 评估针对高脂功能的新型治疗策略.
主要方法:
- 复习先进的蛋白质和脂质组学研究.
- 功能性HDL测定分析 (例如胆固醇排放能力).
- 检查针对高血糖向治疗的临床试验结果.
主要成果:
- 功能障碍的HDL因氧化和炎症过程而受损,失去保护功能.
- 高亮度白细胞的组合重塑是功能异质性的基础.
- 功能性测量 (胆固醇排放) 与结果的相关性比HDL-C水平更好.
结论:
- 优先考虑HDL质量而不是度对于心血管风险评估至关重要.
- 需要对功能性HDL测定进行标准化.
- 将高密度胆固醇向治疗与代谢药物相结合,可以恢复高密度胆固醇的保护性表型.
相关概念视频
Atherosclerosis I: Introduction
853
Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
853
Coronary Artery Disease II: Pathophysiology
355
Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
355
Atherosclerosis III: Management
307
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
307
Coronary Artery Disease I: Introduction
863
Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
863
Blood Studies for Cardiovascular System III: Serum Lipid Profile
540
Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
540
Coronary Artery Disease IV: Preventive Measures
578
Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
578


